LivingGLP1
Study S000227

Behavioral Therapy With and Without GLP-1 Analogue in Patients With Morbid Obesity and Binge Eating Disorder: A Clinical Prospective Observational Study on Body Weight, Binge Eating Behavior, and Harmful Coping Strategies

Registration

Registration
NCT07042672
Acronym
BETTER-GLP1
Study type
OBSERVATIONAL
Status
RECRUITING
Enrollment
80
Start
2025-07-01
Primary completion
2027-11-05
Lead sponsor
Haukeland University Hospital
Conditions
Binge Eating Disorder Associated With Obesity; Binge Eating Disorder; Eating Disorder Binge; Eating Disorders; GLP-1; CBT; Obesity &Amp; Overweight
Interventions
DRUG:GLP-1; BEHAVIORAL:CBTe Group Therapy
Results posted
FALSE
Individual participant data sharing
NO
Secondary identifiers
NIH:2025

Registered primary outcomes

  • Change in EDE-Q Global Score From Baseline to 12 Months [Baseline and 12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.